Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Hundreds of international flights canceled due to typhoon
08/13/2025 02:11 PM - Business
Taiwan shares close up 0.88%
08/13/2025 01:58 PM - Society
Typhoon Podul makes landfall in Taiwan's Taitung County
08/13/2025 01:44 PM - Society
Rail, ferry services suspended due to Typhoon Podul
08/13/2025 01:12 PM - Cross-Strait
Rules on restoring Taiwan citizenship to be tightened over China fears
08/13/2025 12:54 PM